Two Onc Docs podcast

Player FM - Internet Radio Done Right

تمت الإضافة منذ قبل two أعوام

المحتوى المقدم من Sam and Karine. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Sam and Karine أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.

On the Bus with Troy Vollhoffer

1
From Backroom Bars to Broadway with Dustin Lynch 36:27

منذ 25 يومًا36:27

التشغيل لاحقا

قوائم

إعجاب

احب

36:27

Not many artists actually hail from Tennessee, but the scenic valleys and rolling hills of The Volunteer State are part of Dustin Lynch’s DNA. In this episode of On the Bus, Country Thunder CEO Troy Vollhoffer sits down with Dustin to discuss his journey from playing fraternity parties and weddings across the southeast to being the first country artist with a club residency at the Wynn in Las Vegas. Plus, stick around for our new segment, Thunder Strike, where Troy features upcoming festival performer Riley Green’s hit song “Damn Good Day to Leave” to give you a taste of what’s to come at Country Thunder in 2025.…

Two Onc Docs

منزل السلاسل•Feed

This is Sam and Karine, and we are Two Onc Docs! We both graduated from our Heme/Onc fellowships in 2021 and became board certified in both Hematology and Oncology. Our mission with Two Onc Docs is to create short board review episodes that you can listen to on your drive to work, while you make your morning coffee, or between pages on call. This is intended to be a supplement to other established board studying resources for busy trainees. *This podcast is intended to be an educational resource for health care providers.*

146 حلقات

#Fitness #Medicine #Sam And Karine

Two Onc Docs

updated منذ 7 ساعات

منزل السلاسل•Feed

146 حلقات

#Fitness #Medicine #Sam And Karine

كل الحلقات

Two Onc Docs

1
Testicular Cancer 2025 UPDATE Part 1 (Seminoma) 12:01

منذ 7 hours12:01

12:01

This week’s episode is part 1 of testicular cancer 2025 updates. We had the honor of interviewing Dr. Larry Einhorn a true legend when it comes to the management of testicular CA last year, released in April 2024, but today, we will be repeating a quick overview of risk factors and staging for testicular cancer, as well as the management of seminoma.…

Two Onc Docs

1
Chronic Lymphocytic Leukemia (CLL) 2025 UPDATE 12:42

منذ 14 يومًا12:42

12:42

This week’s episode will be focusing on an update of CLL. We will go over important details on the presentation, diagnosis, prognostic factors, and treatment options for initial and refractory disease, as well as key toxicities.

Two Onc Docs

1
Metastatic Prostate Cancer x Dr. Charles Ryan 2025 UPDATE 34:53

منذ 21 يومًا34:53

34:53

We are so excited to welcome back Dr. Charles (Chuck) Ryan for our 2025 prostate cancer updates. Dr. Ryan is an internationally recognized GU oncologist and prostate cancer expert, seeing patients at MSK in NYC, and co-host of the podcast 'The Good News About Cancer'. This episode will cover metastatic prostate cancer including board review pearls & key toxicities of treatments, upcoming exciting research in PCa, and advice for trainees/early career faculty.…

Two Onc Docs

1
Localized Prostate Cancer x Dr. Charles Ryan 2025 UPDATE 35:49

منذ 27 يومًا35:49

35:49

We are so excited to welcome Dr. Charles (Chuck) Ryan for our 2025 prostate cancer updates. Dr. Ryan is an internationally recognized GU oncologist and prostate cancer expert, seeing patients at Memorial Sloan Kettering in NYC. This episode will cover localized prostate cancer, risk factors, staging, role of PET PSMA, risk stratification, treatments, as well as introduce biochemical recurrence.…

Two Onc Docs

1
Metastatic Colon Cancer 2025 UPDATE 23:45

منذ 5 weeks23:45

23:45

Today’s episode is focusing on what you need to know regarding metastatic colon cancer. This will include the need to know about molecular studies, treatment, and surgery for oligometastatic disease. There has been three breakthroughs since we last covered this topic in the treatment of metastatic CRC based on molecular findings that we will go over today.…

Two Onc Docs

1
Localized Colon Cancer 2025 UPDATE 21:07

منذ 6 weeks21:07

21:07

Today’s episode is focusing on what you need to know regarding early stage colorectal cancer (CRC) as of 2025. The last time we covered this topic was in 2023 and things continue to change. We will go over all the important details on the diagnosis, presentation, diagnostic work-up, role of ctDNA, staging, treatment, and surveillance of localized CRC.…

Two Onc Docs

1
Multiple Myeloma 2025 x Dr. Vincent Rajkumar Part 2 19:13

منذ 7 weeks19:13

19:13

We are so honored to welcome back Dr. S. Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota. He is also Editor-In-Chief of Blood Cancer Journal and the Chairperson of the Board of the International Myeloma Foundation. This week’s episode will be focusing on additional pearls for the treatment of Multiple Myeloma including options for refractory disease, as well as advice for trainees.…

Two Onc Docs

1
ASCO GU 2025 Takeaways 13:22

منذ 8 weeks13:22

13:22

Today we will be discussing a few of the exciting abstracts presented at ASCO GU (Feb 13-15 2025) for prostate CA (TALAPRO-2), bladder CA (EV-302, CM-274, NIAGARA), and RCC (COSMIC-313, KIM-1).

Two Onc Docs

1
ASCO GU 2025 Preview 10:46

منذ 9 weeks10:46

10:46

Today we will be discussing exciting data to come at ASCO GU (Feb 13-15 2025) in terms of research for prostate CA, bladder CA, RCC and other rarer GU tumors.

Two Onc Docs

1
Multiple Myeloma 2025 x Dr. Vincent Rajkumar Part 1 17:34

منذ 10 weeks17:34

17:34

We are so honored to welcome Dr. S. Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota. He is also Editor-In-Chief of Blood Cancer Journal and the Chairperson of the Board of the International Myeloma Foundation. This week’s episode will be focusing on Multiple Myeloma symptoms, diagnostic criteria, work-up and initial treatment.…

Two Onc Docs

1
Small Cell Lung Cancer 2025 x Dr. Stephen Liu Part 2 34:24

منذ 11 weeks34:24

34:24

This week’s episode will be focusing on additional details for Extensive Stage Small Cell Lung Cancer (SCLC), options for relapsed/refractory disease & advice for trainees. We are so excited to welcome back Dr. Stephen Liu international expert for lung cancer, Director of Thoracic Oncology & Developmental Therapeutics at Georgetown Lombardi Cancer Center and Co-Host of the IASLC Podcast.…

Two Onc Docs

1
Small Cell Lung Cancer 2025 x Dr. Stephen Liu Part 1 23:32

منذ 12 weeks23:32

23:32

This week’s episode will be focusing on Small Cell Lung Cancer (SCLC). We will go all the important details on risk factors, diagnostic work-up, staging and treatment of both locoregional and metastatic SCLC. We are so excited to welcome Dr. Stephen Liu international expert for lung cancer, Director of Thoracic Oncology & Developmental Therapeutics at Georgetown Lombardi Cancer Center and Co-Host of the IASLC Podcast.…

Two Onc Docs

1
Polycythemia Vera 2025 12:26

منذ 13 weeks12:26

12:26

This week’s episode will be re-discussing one of the myeloproliferative neoplasms, Polycythemia Vera (PV). We will go over the important details on the diagnosis, risk stratification for thrombus and treatment.

Two Onc Docs

1
Immune Related Adverse Events (irAEs) 17:30

منذ 14 weeks17:30

17:30

Happy New Year! This week’s episode will go over important details related to immune checkpoint inhibitors (ICIs) and immune-related adverse events (irAEs), with general management strategies for each of the most common iRAEs.

Two Onc Docs

1
Thymoma x Dr. Pat Loehrer Part 2 19:34

منذ 17 weeks19:34

19:34

This week’s episode will be focusing on advanced Thymoma and Thymic Carcinoma, board review pearls, and career advice for trainees & early career oncologists. We are back with Dr. Pat Loehrer, who is a legend when it comes to the treatment of Thymoma.

Two Onc Docs

1
Thymoma x Dr. Pat Loehrer Part 1 22:55

منذ 18 weeks22:55

22:55

This week’s episode will be focusing on localized Thymoma and Thymic Carcinoma. We are so honored to have Dr. Pat Loehrer here with us today who is a legend when it comes to the treatment of Thymoma. He is a Distinguished Professor of Medicine Joseph W. and Jackie J. Cusick Professor of Oncology, Director for Center of Global Oncology and Health Equity and prior cancer center director at Indiana University.…

Two Onc Docs

1
Metastatic Non-Small Cell Lung Cancer 2024 UPDATE 20:48

منذ 20 weeks20:48

20:48

This week’s episode will be focusing on Metastatic Non-small Cell Lung Cancer (NSCLC). We are back with Dr. Jennifer Marks, Thoracic Oncologist at the Dana-Farber Cancer Institute. We will go all the important details on the quickly growing and changing systemic therapy options including traditional chemotherapy, immunotherapy and targeted agents…

Two Onc Docs

1
Localized Non-Small Cell Lung Cancer 2024 UPDATE 25:15

منذ 21 weeks25:15

25:15

This week’s episode will be focusing on Localized Non-small Cell Lung Cancer (NSCLC). We are very excited to have Dr. Jennifer Marks with us today. Dr. Marks is a thoracic oncologist at the Dana-Farber Cancer Institute, Instructor in Medicine at Harvard Medical School, who also recently took her oncology boards. We will go all the important details on basic of staging, treatment for resectable and unresectable localized NSCLC, and updates in terms of peri-operative and targeted therapies…

Two Onc Docs

1
Hemoglobin Electrophoresis 19:39

منذ 22 weeks19:39

19:39

This week’s episode will be focusing on Hemoglobin (Hb) electrophoresis. We will go important details on what Hb electrophoresis is, the normal breakdown of adult hemoglobin, and specific hemoglobinopathies (thalassemias, sickle cell, Lepore...) you can be tested on during your ITEs and hematology boards.…

Two Onc Docs

1
Special Guest: CRC Survivor & Patient Advocate Marisa Peters 26:27

منذ 24 weeks26:27

26:27

In honor of National Family Health History Month in November, we have a special guest. We share the story of an incredible colorectal cancer survivor and health advocate, Marisa Peters, who was a Broadway vocalist and a very healthy, active mom to 3 young boys, yet diagnosed with stage 3 rectal cancer at only 39 years old.…

Two Onc Docs

1
Metastatic Breast Cancer 2024 UPDATE 20:14

منذ 25 weeks20:14

20:14

This week’s episode is part 3 of 2024 updates focusing on treatment options for metastatic breast cancer. We will cover important details on systemic therapy related to metastatic breast cancer & key toxicities. We are honored to have Dr. Eleonora Teplinsky, a board-certified medical oncologist specializing in breast and gynecologic oncology, as a guest sharing some pearls.…

Two Onc Docs

1
Localized Breast Cancer 2024 UPDATE 28:49

منذ 26 weeks28:49

28:49

This week’s episode is part 2 of 2024 updates focusing on treatment options for localized breast cancer. We will discuss important details on radiation, as well as therapies based on ER/PR/her2 receptor status. We are honored to have Dr. Eleonora Teplinsky, a board-certified medical oncologist specializing in breast and gynecologic oncology, as a guest sharing some pearls.…

Two Onc Docs

1
Breast Cancer Screening, Prevention & Intro 2024 UPDATE 16:36

منذ 27 weeks16:36

16:36

We are continuing our 2024 updates, this week’s episode will be an intro to breast cancer. Today’s will include high yield tips on screening, prevention, ductal carcinoma in situ DCIS, lobular carcinoma in situ LCIS, as well as introduce invasive localized disease.

Two Onc Docs

1
Board Review Resources 2024 15:25

منذ 28 weeks15:25

15:25

This week’s episode will be discussing our favorite heme/onc board review resources. This is pertinent to new fellows who are starting to think about how to study during fellowship, preparation for ITEs and of course studying for the boards.

Two Onc Docs

1
ESMO 2024 GU Update 18:10

منذ 29 weeks18:10

18:10

We are doing a special episode this week to cover some of the key GU abstracts from ESMO 2024. We cover an update on the STAMPEDE prostate cancer trial, SUNNIFORECAST in non-clear cell renal cell carcinoma, SunRISe-4 in bladder cancer, and more.

Two Onc Docs

1
Palliative Care x Dr. Janet Abrahm Part 2 19:55

منذ 30 weeks19:55

19:55

In Part 2 we discuss how to deal with patients of different backgrounds, navigating spiritual & emotional challenges in oncology, tips for physicians who are experiencing moral distress & compassion fatigue, as well as general career advice. We are so honored to have Dr. Janet Abrahm with us who is a national leader in the field of palliative care and a professor at Harvard Medical School.…

Two Onc Docs

1
Heme & Onc Fellow Board Review Tips 2024 16:03

منذ 31 weeks16:03

16:03

This week’s episode will be focusing on final board review tips. We will go over our highest yield cheat sheet topics, and how we prepared the days leading up to our exam. We took our boards three years ago now, but the stress leading up to the exam is certainly fresh in our minds.

Two Onc Docs

1
Palliative Care x Dr. Janet Abrahm Part 1 27:44

منذ 33 weeks27:44

27:44

In Part 1 we discuss how to explain palliative care to patients, pain and anti-emetic management, non-pharmacologic strategies, and current innovations within palliative care. We are so honored to have Dr. Janet Abrahm here with us who is a national leader in the field of palliative care and a professor at Harvard Medical School.…

Two Onc Docs

1
Hemophilia 2024 UPDATE 16:22

منذ 34 weeks16:22

16:22

This week’s episode will be repeating our episode on hemophilias with some updates. We will go over all high yield facts regarding both hemophilia A and B for your boards and end with a little bit about acquired hemophilias.

Two Onc Docs

1
ASCO 2024 Plenary: NADINA Trial Neoadjuvant Ipi/Nivo vs Adjuvant Nivo for Resectable Stage III Melanoma 10:09

منذ 35 weeks10:09

10:09

This week’s episode will be discussing updates from ASCO 2024 next with the practice changing NADINA trial presented on the Sunday of ASCO by Dr. Christian Blank during the plenary sessions: A multicenter, randomized, phase 3 trial comparing the efficacy of neoadjuvant ipilimumab plus nivolumab with standard adjuvant nivolumab in macroscopic resectable stage III melanoma. We discuss the staging and prior standard of treatment for locally advanced melanoma, key findings from NADINA, and how these data may impact clinical practice.…

مرحبًا بك في مشغل أف ام!

يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.